Back to Journals » OncoTargets and Therapy » Volume 15
Corrigendum
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
RANKL/RANK Pathway Abrogates Cetuximab Sensitivity in Gastric Cancer Cells via Activation of EGFR and c-Src [Corrigendum]
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
4,227 | Dovepress* | 4,191+ | 260 | 4,451 | |
PubMed Central* | 36 | 25 | 61 | ||
Totals | 4,227 | 285 | 4,512 | ||
*Since 13 May 2022 |
View citations on PubMed and Google Scholar